By modifying a clinical ultrasound array system, we develop a novel handheld photoacoustic probe for image-guided needle biopsy. The integration of optical fiber bundles for pulsed laser light delivery enables photoacoustic image-guided insertion of a needle into rat axillary lymph nodes with accumulated indocyanine green ͑ICG͒. Strong photoacoustic contrast of the needle is achieved. After subcutaneous injection of the dye in the left forepaw, sentinel lymph nodes are easily detected, in vivo and in real time, beneath 2-cm-thick chicken breast overlaying the axillary region. ICG uptake in axillary lymph nodes is confirmed with fluorescence imaging both in vivo and ex vivo. These results demonstrate the clinical potential of this handheld photoacoustic system for facile identification and needle biopsy of sentinel lymph nodes for cancer staging and metastasis detection in humans.
Introduction
Sentinel lymph node ͑SLN͒ biopsy has become the standard of care for patients diagnosed with breast cancer, replacing axillary lymph node dissection. Biopsy of the lymph nodes directly draining the tumor area can accurately stage cancer to guide therapeutic decisions. Ultrasound ͑US͒ guidance of minimally invasive interventions is widely performed, leading to improved treatment outcomes and shorter recovery. 1, 2 Realtime, noninvasive, nonionizing, and portable US imaging is currently the primary method for guiding targeted needle biopsies and nerve blockings. 3, 4 Photoacoustic ͑PA͒ imaging is a nonionizing and noninvasive hybrid imaging technique that combines strong optical absorption contrast with high ultrasonic spatial resolution. 5 Since ultrasonic scattering is 2 to 3 orders of magnitude less than optical scattering, PA imaging can break through the fundamental depth limitations of pure optical imaging. 6 Using intrinsic contrasts such as hemoglobin or melanin, PA imaging can provide both morphological and functional information. 5 Moreover, using molecularly targeted exogenous contrast agents, it can also provide molecular information. 5 We previously reported in vivo detection of lymph nodes in rats using a raster-scanning tabletop PA imaging system. Methylene blue, 7 indocyanine green ͑ICG͒, 8 and gold nanoparticles 9 were used as contrast agents. However, this system was relatively slow for clinical applications ͑20 min for a 20-ϫ 20-mm 2 field of view͒, and its imaging head was not handheld. We also reported in vivo PA and US mapping of SLNs in rats using a US array, but the light delivery was not handheld. 10 In this paper, for the first time to our knowledge, we report noninvasive in vivo mapping of deeply positioned ICG-dyed SLNs ͑ϳ2.1 cm͒ in rats using a PA imaging system adapted from a commercial US array system. A US probe integrated with optical fiber bundles for light delivery enabled handheld scanning as in ultrasonagraphy. 11, 12 ICG uptake in SLNs was confirmed by fluorescence imaging. Furthermore, both realtime PA imaging ͓1 frame per second ͑fps͔͒ and US imaging ͑5 fps͒ successfully guided needle insertion in vivo. Figure 1 shows an experimental schematic of the integrated PA and US imaging system, adapted from a clinical US imaging system 10 ͑iU22, Philips Healthcare͒. Raw per-channel PA and US data were both acquired through the modified channel board architecture and transferred to a custom-made data acquisition computer for display and postprocessing. The data acquisition system was synchronized with laser firing. Fourier-beam-formed PA images were displayed at a frame rate of ϳ1 fps. However, the frame rate can be improved to 10 fps, limited by the current laser repetition rate. US images were captured at 5 fps. For this study, we used a linear array US probe ͑L8-4, Philips Healthcare͒ with a nominal bandwidth of 4 to 8 MHz. Light from a tunable dye laser ͑NS, Sirah͒, pumped by a Q-switched Nd:YAG laser ͑PRO-350-10, Newport͒ with a 6.5-ns pulse duration and a 10-Hz pulse repetition rate, was coupled to a multimode fiber bundle ͑CB18043, Fiberguide͒. The fiber bundle was bifurcated and physically integrated with the US probe, enabling handheld scanning. The two optical beams were obliquely incident ͑ ϳ 45 deg͒ on the tissue surface as rectangles ͑2 ϫ 3 cm along the X and Y axes from each bundle͒. An optical wavelength of 810 nm, close to the peak optical absorption wavelength of ICG ͑806 nm in albumin͒, was utilized. Light fluence on the skin was less than 1.5 mJ/ cm 2 , well below the American National Standards Institute safety limits. 13 Tabletop PA imaging systems and the previously reported study using this modified Philips system required a water tank, which is clinically undesirable. Here, US gel was applied to directly couple the PA probe to the surface of the tissue.
Methods and Materials
Animal handling was performed according to the guidelines on the care and use of laboratory animals at Washington University in St. Louis. Sprague Dawley rats ͑ϳ200 g͒ were initially anesthetized using a mixture of ketamine ͑85 mg/ kg͒ and xylazine ͑15 mg/ kg͒. To test the clinical feasibility of this technique on humans, we intentionally increased the imaging depth by laying ϳ2 cm of chicken tissue atop the rat. After depilation in the left axillary region, we first obtained a control PA image before the injection of ICG. After intradermally injecting 0.1 ml of 1-mM ICG into the left forepaw, we acquired a series of PA images to monitor the ICG uptake in the SLN dynamically. Then, we demonstrated PA imageguided needle ͑18 gauge͒ insertion in vivo. Here, we mechanically fixed the PA imaging probe to avoid motion artifacts. After PA imaging, in vivo fluorescence imaging was performed with a time-domain diffuse optical imaging system ͑eXplore Optix, Advance Research Technologies͒ to confirm ICG uptake. Then, ex vivo fluorescence imaging was performed to confirm uptake in the lymph nodes using a planar reflectance imaging system ͑Kodak IS4000MM, Carestream Health͒ with 755-nm excitation and 830-nm detection.
Results and Discussion
To investigate the feasibility of PA and US mapping of SLNs with ICG, we imaged the left axillary region in a rat before and after ICG injection. A control PA B-scan image was acquired before injection ͓Fig. 2͑a͔͒. Immediately after injec- Fig. 2͑d͒ . As the needle was inserted into the chicken tissue in vivo, it was ultrasonically tracked in real time ͑Video 2͒, but the SLN was not detected ultrasonically. The needle progression could also be detected photoacoustically, as shown in Fig. 2͑e͒ and Video 3. PA imaging was able to detect the SLN clearly. Comparison of the two videos clearly shows that PA imaging has much higher contrast than US imaging in needle tracking under the current experimental condition. We quantified the image contrasts of the needles in both images within the regions of interest indicated by the yellow dotted boxes in Figs. 2͑d͒ and 2͑e͒. The PA image contrast of the needle was 8.5Ϯ 4 ͑standard deviation͒, whereas the US image contrast was 1.2Ϯ 0.04 ͑standard deviation͒. However, in neither case was the tracking of the needle optimized and both imaging modalities were highly operator-dependant. Fluorescence images obtained after PA imaging confirmed ICG uptake in the SLN ͓Fig. 3͑a͔͒. Further, we imaged fluorescently three dissected lymph nodes ͑LNs͒ from the left axillary region ͓Fig. 3͑b͔͒. Only the first draining node, the sentinel node, generated strong fluorescence.
Conclusions
We developed a noninvasive, nonionizing, real-time, and handheld PA and US imaging system using a modified clinical US imaging system. In vivo mapping of rat SLNs at an imaging depth of ϳ2.1 cm was successfully accomplished following ICG injection. Further, PA imaging enabled guided needle insertion with strong contrast in vivo. This technique is highly translatable to clinical applications for image-guided SLN biopsy, nerve blockings, and many others. 
